Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
64.4 USD | -1.57% | +0.73% | +17.97% |
Apr. 17 | Ani Pharmaceuticals Insider Sold Shares Worth $1,500,589, According to a Recent SEC Filing | MT |
Apr. 09 | ANI Pharmaceuticals, Inc. Announces the Launch of Baclofen Oral Suspension | CI |
Financials (USD)
Sales 2024 * | 535M | Sales 2025 * | 576M | Capitalization | 1.37B |
---|---|---|---|---|---|
Net income 2024 * | 22M | Net income 2025 * | 34M | EV / Sales 2024 * | 2.42 x |
Net cash position 2024 * | 80.28M | Net cash position 2025 * | 188M | EV / Sales 2025 * | 2.06 x |
P/E ratio 2024 * |
50.9
x | P/E ratio 2025 * |
31.9
x | Employees | 642 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.64% |
Latest transcript on ANI Pharmaceuticals, Inc.
1 day | -1.07% | ||
1 week | -0.08% | ||
Current month | -5.35% | ||
1 month | -5.96% | ||
3 months | +18.53% | ||
6 months | +12.65% | ||
Current year | +18.66% |
Managers | Title | Age | Since |
---|---|---|---|
Nikhil Lalwani
CEO | Chief Executive Officer | 46 | 20-09-07 |
Stephen Carey
DFI | Director of Finance/CFO | 53 | 16-05-05 |
Patrick Walsh
CHM | Chairman | 63 | 18-05-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Haughey
BRD | Director/Board Member | 60 | 18-04-30 |
Antonio Pera
BRD | Director/Board Member | 66 | 20-08-05 |
David Nash
BRD | Director/Board Member | 68 | 18-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.95% | 11 M€ | -6.03% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 65.05 | -0.58% | 754 |
24-04-24 | 65.43 | -1.07% | 83,439 |
24-04-23 | 66.14 | +0.79% | 85,940 |
24-04-22 | 65.62 | +0.21% | 95,322 |
24-04-19 | 65.48 | +1.39% | 207,268 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.66% | 1.37B | |
+25.61% | 660B | |
+22.88% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+12.30% | 219B | |
-9.57% | 196B | |
+6.54% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- ANIP Stock